Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

Hanyang University Seoul Hospital

Status: Completed

Conditions: Hemolysis; Vaccine Reaction; Covid19; End-stage Renal Disease

Treatments: Diagnostic Test: Elecsys Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany), 2) ACCESS SARS-CoV-2 IgG II (Beckman Coulter, Inc. USA)

Study type: Observational

Funder types: Other

Identifiers

NCT04871945

2021-02-033

Details and patient eligibility

About

The aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis. To this end, the level of neutralizing antibody of patients under hemodialysis is compared to that of healthy population.

Enrollment: 31 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• The person who is vaccinated with ChAdOx1 (COVID-19 vaccine)
• The person who agrees with the protocol of the study

Exclusion criteria

• Age < 18 years
• Pregnants
• Experience of COVID-19 infection